Ann: Initial Director Interest Notices x 3-MNQ.AX, page-5

The new Management of eAPT have to get approval for their incentive package at the AGM. I am sure it will go through as if they make money then we all make money as one of the milestones is commercialisation. We can see from the RAP example that in this space of smart phone enabled medical devices, it is possible to drive market caps in the 100's of millions prior to getting approval to sell the commercial product. It is all about communicating to the market the progress towards getting FDA and TGA approval, along with good promotion and news flow. I hear Management have plans for regular roadshows and broker meetings so that should help get broader support and push the price. With regular broker briefings this should really move.